Betta Pharmaceuticals Co.,Ltd.’s Net Profit Rose 231.3% in First Three Quarters of 2023

Betta Pharmaceuticals Co.,Ltd. (贝达药业股份有限公司) (300558.SZ) reported a net profit of 294.1 million yuan in the first three quarters of 2023, up 231.3% year-on-year.

Meanwhile, the company posted 2 billion yuan in revenue, up 22.9% year-on-year.

At the end of the reporting period, it had 8.8 billion yuan in total assets and 3.5 billion yuan in total liabilities, with a liability-to-asset ratio of 39.5%.